Corey M Forster, Shannon Halls, Sabrina Allarakhia, Dimpy Modi, Wiley Chung, Kendra Derry, Genevieve Digby, Jennifer Flemming, John McGugan, Heather Mackulin, Steven Montague, Stephanie Sibley, Samuel A Silver, Angela Sirosky-Yanyk, Andrew Stevens, Kerstin de Wit, Liying Zhang, Jeannie Callum
BACKGROUND: Intravenous albumin has limited indications supported by randomised controlled trials, yet it is often prescribed for indications not supported by evidence. AIM: To reduce unnecessary transfusion of albumin. INTERVENTIONS: Under the leadership of a multidisciplinary quality improvement team, evidence-based recommendations were disseminated in tandem with a new electronic order set, an educational strategy, qualitative interviews with prescribers and a return policy change to reduce wastage...
April 15, 2024: BMJ Open Quality